You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
啟明醫療-B(02500.HK)成立啟明醫療全球心臟瓣膜創新中心
格隆匯 03-01 18:07

啟明醫療-B(02500.HK)公吿,將在以色列成立啟明醫療全球心臟瓣膜創新中心(Venus Global Heart Valve Innovation Center),並任命Amir Gross為啟明醫療全球心臟瓣膜創新中心負責人。Amir Gross也是二尖瓣三尖瓣創新療法公司Cardiovalve Ltd.(Cardiovalve)的首席執行官,Cardiovalve已在2022年1月份由公司完成100%股權收購。 

啟明醫療全球心臟瓣膜創新中心將致力於對突破性創新治療技術進行孵化,進一步完善本公司的全球化創新體系與產品佈局,專注包括利用Cardiovalve技術平台研發新一代治療主動脈瓣反流技術,數字健康技術在瓣膜系統的應用等,並在適當時機將技術轉移至中國和全球其它區域。

同時,公司也將啟用啟明醫療全球心臟瓣膜創新中心進行中國-以色列工程師交換培訓項目,以整合兩國獨特的資源深度培育創新人才,為長期發展奠定紮實基礎。

董事會深信,啟明醫療全球心臟瓣膜創新中心的建立將顯著推進公司國際化進程,促進深化創新體系,為臨牀醫生與患者帶來高價值的創新醫療器械。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account